Author page: Kathrin Folkendt

Compass Diversified Partners with The Honey Pot Company in $380M Deal to Expand Feminine Care Offerings

Compass Diversified (CODI), known for its portfolio of leading middle-market businesses, has entered into a partnership with The Honey Pot Company, a brand specializing in “better-for-you” feminine care products. The agreement, which carries an enterprise value of $380 million, aims to reinforce The Honey Pot Company’s commitment to providing comprehensive and holistic feminine care systems. Originating from a personal need for healthier…

Oura Ring & Natural Cycles for Birth Control or Fertility Tracking: Everything You Need to Know! (2024 Review)

Initially the Oura Ring promised better sleep, but its collaboration with Natural Cycles delivered something I hadn’t envisioned: a smart, straightforward way to manage my reproductive health. Starting in August 2022, I began using an Oura Ring alongside Natural Cycles initially for contraception. This partnership has transformed my approach to fertility and contraception, evolving from a background concern into an integrated part…

New Nature Study by Flo Health Reveals How Acute Stress Affects Women’s Pain Perception Amidst Russia-Ukraine War

In a study published by Nature Portfolio Journal: Mental Health Research, Flo Health has illuminated the effects of acute stress on pain perception among women during the ongoing Russia-Ukraine war. This research, marking the first real-world examination of ‘stress-induced analgesia’ (SIA), offers critical insights into the relationship between heightened stress and reduced pain sensitivity. For this study Flo, a women’s health app…

Eli Lilly’s LillyDirect: Implications for Direct-to-Consumer Women’s Health Startups

With both CES and the JP Morgan conference on the horizon, there’s bound to be plenty to discuss. But before we dive into conference week, let’s delve into a topic that dominated week one of 2024: Eli Lilly’s recent venture, LillyDirect. In today’s Inner Circle brief, we’ll dissect Lilly’s foray into the DTC domain, its significance, and potential impacts on women’s health…

Kindbody’s Growth Ambitions Spotlight Tension Between Venture Capital and Patient Care

In a recent somewhat buzzworthy Bloomberg report, fertility scale-up Kindbody, a trailblazer and well-known unicorn in the femtech world, has come under scrutiny for allegedly nudging its doctors to ramp up egg retrievals — all in the pursuit of beefier profitability margins and the alluring prospect of an IPO. While Kindbody’s growth tactics are currently center stage, it’s crucial to see this…

Introducing Femtech Bot: The New AI Companion on Your Femtech Journey

As we navigate towards the end of the transformative year 2023 was in so many ways, it’s clear that AI is not just a buzzword but a game-changer across many industries including media. At Femtech Insider, we’re ever so curious when it comes to innovation and of course we do the best to keep up and evolve our platform to best serve…

Inside FemTech Fund III: How Portfolia Founder Trish Costello Leads the Charge in Women’s Health Investing

Portfolia, a U.S.-based venture capital firm known for its diverse investment portfolio, recently announced the launch of FemTech Fund III, a new investment vehicle focusing on women’s health. This fund, the third of its series, reflects the firm’s dedication to the women’s health and femtech sectors. Founded by Trish Costello in 2014, Portfolia stands out in the venture capital world with its…